• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index

    12/11/20 8:05:00 PM ET
    $TTWO
    $TEAM
    $AEP
    $PTON
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $TTWO alert in real time by email

    NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 21, 2020.

    The following six companies will be added to the Index: American Electric Power Company, Inc. (Nasdaq: AEP), Marvell Technology Group Ltd. (Nasdaq: MRVL), Match Group, Inc. (Nasdaq: MTCH), Okta, Inc. (Nasdaq: OKTA), Peloton Interactive, Inc. (Nasdaq: PTON), Atlassian Corporation Plc (Nasdaq: TEAM).

    The Nasdaq-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market® and dates to January 1985 when it was launched along with the Nasdaq Financial-100 Index®, which is comprised of the 100 largest financial stocks on Nasdaq®. These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100 is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index is the basis of the Invesco QQQ Trust (Nasdaq: QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index performance. In addition, options, futures and structured products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), Citrix Systems, Inc. (Nasdaq: CTXS), Expedia Group, Inc. (Nasdaq: EXPE), Liberty Global plc (Nasdaq: LBTYA/LBTYK), Take-Two Interactive Software, Inc. (Nasdaq: TTWO), Ulta Beauty, Inc. (Nasdaq: ULTA).

    Information
    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    American Electric Power Company, Inc. – https://www.aep.com/

    Marvell Technology Group Ltd. – https://www.marvell.com/

    Match Group, Inc. – https://www.mtch.com/

    Okta, Inc. – https://www.okta.com/

    Peloton Interactive, Inc. – https://www.onepeloton.com/

    Atlassian Corporation Plc – https://www.atlassian.com/

    About Nasdaq Global Indexes
    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.

    About Nasdaq
    Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

    Media Relations Contact
    Emily Pan
    (646) 637-3964
    [email protected]

    Issuer & Investor Contact
    Index Client Services
    [email protected]

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    -NDAQG-


    Get the next $TTWO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TTWO
    $TEAM
    $AEP
    $PTON

    CompanyDatePrice TargetRatingAnalyst
    BioMarin Pharmaceutical Inc.
    $BMRN
    1/28/2026$80.00Overweight
    Barclays
    Ulta Beauty Inc.
    $ULTA
    1/21/2026$790.00Outperform → Strong Buy
    Raymond James
    BioMarin Pharmaceutical Inc.
    $BMRN
    1/20/2026$98.00Hold → Buy
    Canaccord Genuity
    Marvell Technology Inc.
    $MRVL
    1/15/2026$105.00Outperform
    RBC Capital Mkts
    Ulta Beauty Inc.
    $ULTA
    1/14/2026$700.00Hold
    Jefferies
    Okta Inc.
    $OKTA
    1/14/2026$120.00Equal-Weight → Overweight
    Stephens
    American Electric Power Company Inc.
    $AEP
    1/12/2026$122.00Buy → Neutral
    BofA Securities
    Ulta Beauty Inc.
    $ULTA
    1/8/2026Buy
    Deutsche Bank
    More analyst ratings

    $TTWO
    $TEAM
    $AEP
    $PTON
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Okta Inc.

    SCHEDULE 13G/A - Okta, Inc. (0001660134) (Subject)

    1/30/26 2:15:58 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    SEC Form 40-17G filed by Invesco QQQ Trust, Series 1

    40-17G - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    1/30/26 9:58:27 AM ET
    $QQQ

    SEC Form 8-K filed by BioMarin Pharmaceutical Inc.

    8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)

    1/29/26 4:19:58 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Rascoff Spencer M bought $445,691 worth of shares (14,000 units at $31.84), increasing direct ownership by 9% to 165,128 units (SEC Form 4)

    4 - Match Group, Inc. (0000891103) (Issuer)

    11/20/25 4:15:48 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    Director Belsky Scott bought $250,905 worth of shares (1,476 units at $169.99) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    11/4/25 4:28:42 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Director Belsky Scott bought $239,752 worth of shares (1,566 units at $153.10) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    10/2/25 5:54:20 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on BioMarin Pharmaceutical with a new price target

    Barclays resumed coverage of BioMarin Pharmaceutical with a rating of Overweight and set a new price target of $80.00

    1/28/26 7:15:50 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ulta Beauty upgraded by Raymond James with a new price target

    Raymond James upgraded Ulta Beauty from Outperform to Strong Buy and set a new price target of $790.00

    1/21/26 8:31:04 AM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    BioMarin Pharmaceutical upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded BioMarin Pharmaceutical from Hold to Buy and set a new price target of $98.00

    1/20/26 8:41:11 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Meintjes Willem A converted options into 47,304 shares and covered exercise/tax liability with 19,664 shares, increasing direct ownership by 18% to 184,111 units (SEC Form 4)

    4/A - Marvell Technology, Inc. (0001835632) (Issuer)

    1/30/26 5:57:02 PM ET
    $MRVL
    Semiconductors
    Technology

    CEO, Co-Founder Cannon-Brookes Michael sold $911,895 worth of shares (7,665 units at $118.97) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    1/30/26 4:17:18 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Director Farquhar Scott sold $911,895 worth of shares (7,665 units at $118.97) (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    1/30/26 4:14:15 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    "The Best in the World" CM Punk Graces WWE® 2K26 Cover as Four New Match Types, Upgrades to All Game Modes, and Unprecedented Roster Ensure The Show Never Stops

    Highlights include King of Kings Edition, Attitude Era Edition, Monday Night War Edition, new interactive environments, updated storyline in The Island, expanded customization features, and more Today, 2K announced WWE® 2K26, the newest installment of the flagship WWE video game franchise developed by Visual Concepts, will be available starting March 6 for PlayStation®5 (PS5®), Xbox Series X|S, Nintendo Switch™ 2, and PC via Steam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260130185664/en/Today, 2K announced WWE® 2K26, the newest installment of the flagship WWE video game franchise developed by Visual Concepts, will be av

    1/30/26 1:34:00 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Expedia Group and Affirm deepen partnership, with US exclusivity and plans for further expansion

    Expedia Group (NASDAQ:EXPE) and Affirm (NASDAQ:AFRM) are making it easier for travelers to move from planning to booking with confidence. The companies today announced an expanded, multi-year partnership, making Affirm the exclusive provider of Buy Now, Pay Later installment payment methods for lodging and packages across Expedia Group's flagship brands in the US, including Expedia, Hotels.com and Vrbo. Affirm will also be available to Canadian travelers on select properties in the coming weeks. Eligible travelers shopping for hotels and packages on Expedia, and properties on Hotels.com and Vrbo will receive a real-time approval decision and can choose from customized monthly payment plan

    1/30/26 9:00:00 AM ET
    $AFRM
    $EXPE
    Finance: Consumer Services
    Finance
    Transportation Services
    Consumer Discretionary

    BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility

    SAN RAFAEL, Calif., Jan. 29, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) ("BioMarin") announced today that it priced its previously announced offering of $850 million of 5.500% senior unsecured notes due 2034 (the "Notes"). The issue price of the Notes is 100.000%. The offering is expected to close on February 12, 2026, subject to the satisfaction of customary closing conditions. BioMarin also announced that, in connection with the pending acquisition (the "Acquisition") of Amicus Therapeutics, Inc. ("Amicus"), it completed the syndication of a new $2 billi

    1/29/26 4:05:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 29, 2023 - FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

    For Immediate Release: June 29, 2023 Today, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. “Hereditary hemophilia A is a potentially serious bleeding disorder. Severe cases of hemophilia A can ca

    6/29/23 6:02:12 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    Financials

    Live finance-specific insights

    View All

    BioMarin Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility

    SAN RAFAEL, Calif., Jan. 29, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) ("BioMarin") announced today that it priced its previously announced offering of $850 million of 5.500% senior unsecured notes due 2034 (the "Notes"). The issue price of the Notes is 100.000%. The offering is expected to close on February 12, 2026, subject to the satisfaction of customary closing conditions. BioMarin also announced that, in connection with the pending acquisition (the "Acquisition") of Amicus Therapeutics, Inc. ("Amicus"), it completed the syndication of a new $2 billi

    1/29/26 4:05:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nasdaq Announces Quarterly Dividend of $0.27 Per Share

    NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Nasdaq, Inc. (NASDAQ:NDAQ) has declared a regular quarterly dividend of $0.27 per share on the company's outstanding common stock. The dividend is payable on March 30, 2026 to shareholders of record at the close of business on March 16, 2026. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About Nasdaq Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the br

    1/29/26 7:01:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Reports Fourth Quarter and Full Year 2025 Results; Annual Results Exceed $5.2B in Net Revenue and $4.0B in Solutions Revenue

    NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) today reported financial results for the fourth quarter and full year of 2025. Net revenue1 in 2025 was $5.2 billion, an increase of 13% over 2024, or 12% on an adjusted2 basis. Solutions3 revenue increased 12%, or 11% on an adjusted basis.Fourth quarter 2025 net revenue was $1.4 billion, an increase of 13% on both a reported and organic basis over the fourth quarter of 2024. Solutions revenue grew 13%, or 12% on an organic basis.Annualized Recurring Revenue (ARR)3,4 of $3.1 billion increased 10% on both a reported and organic basis over the fourth quarter of 2024. Annualized SaaS revenue increased 11%, or 13% on an or

    1/29/26 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $TTWO
    $TEAM
    $AEP
    $PTON
    Leadership Updates

    Live Leadership Updates

    View All

    Atlassian Appoints Anil Sabharwal to Board of Directors

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced it is appointing Anil Sabharwal to its Board of Directors, effective February 1, 2026. Anil is Vice President of Product at Google, having held various senior leadership roles at the company for 17 years. In addition, in 2025, Anil served as a technical advisor to Atlassian, overseeing its new partnership with the Atlassian Williams Racing Formula One Team. "Anil builds products people can't live without. He's spent his career helping ambitious companies scale responsibly, and he knows how to make products smarter, more helpful, and more human with AI. That's exactly th

    1/15/26 4:05:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    BioMarin Appoints Arpit Davé Chief Digital and Information Officer

    Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry SAN RAFAEL, Calif., Jan. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced it has appointed Arpit Davé as Executive Vice President, Chief Digital and Information Officer, a new position reporting directly to President and Chief Executive Officer Alexander Hardy. Mr. Davé will be responsible for reimagining and executing BioMarin's enterprise technology strategy, data science and digital transformation to help create value for patients, employees and shareholders.

    1/12/26 4:05:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    $TTWO
    $TEAM
    $AEP
    $PTON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Atlassian Corporation

    SC 13G/A - Atlassian Corp (0001650372) (Subject)

    11/14/24 1:22:40 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/14/24 1:22:39 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/13/24 12:52:42 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary